摘要: Die Annahme, daβ oxidativer Streβ im Rahmen der Atiopathogenese Alzheimer Krankheit (DAT) eine wichtige Rolle spielen konnte, wird heute als vergleichsweise gut abgesicherte Hypothese angesehen. Man knupft dabei an uberlegungen an, die Zusammenhang mit naturlichen Alterungsvorgangen und anderen neurodegenerativen Krankheiten schon intensiv erortert worden sind. Besonders bei Parkinsonschen oder amyotrophen Lateralsklerose dem Modell des neuronalen Zellunterganges durch oxidativen erhebliche Bedeutung zugesprochen (Hal-Liwell 1992, Jenner 1994, Frolich Riederer 1995).
springer.com
sci-hub.st 参考文章(55)
B Bergamasco, L Scarzella, P La Commare, Idebenone, a new drug in the treatment of cognitive impairment in patients with dementia of the Alzheimer type. Functional Neurology. ,vol. 9, pp. 161- 168 ,(1994)
K. Jellinger, Die Alzheimer-Krankheit Springer, Berlin, Heidelberg. pp. 39- 51 ,(1989) , 10.1007/978-3-642-83771-5_5
Deborah L Goad, Claudia M Davis, Pham Liem, C Cecil Fuselier, JR McCormack, KM Olsen, The use of selegiline in Alzheimer's patients with behavior problems. The Journal of Clinical Psychiatry. ,vol. 52, pp. 342- 345 ,(1991)
Trial of d-α-tocopherol in Huntington's disease American Journal of Psychiatry. ,vol. 152, pp. 1771- 1775 ,(1995) , 10.1176/AJP.152.12.1771
Johannes Thome, Gerald Münch, Renate Müller, Reinhard Schinzel, Johannes Kornhuber, Doris Blum-Degen, Ludwig Sitzmann, Michael Rösler, August Heidland, Peter Riederer, None, Advanced glycation endproducts — associated parameters in the peripheral blood of patients with Alzheimer's disease Life Sciences. ,vol. 59, pp. 679- 685 ,(1996) , 10.1016/0024-3205(96)00349-9
Giancarlo Finali, Massimo Piccirilli, Carlo Oliani, Gian Luigi Piccinin, L-Deprenyl Therapy Improves Verbal Memory in Amnesic Alzheimer Patients Clinical Neuropharmacology. ,vol. 14, pp. 523- 536 ,(1991) , 10.1097/00002826-199112000-00005
Geerd Weyer, Helmut Erzigkeit, Dietrich Hadler, Stephan Kubicki, Efficacy and safety of idebenone in the long‐term treatment of Alzheimer's Disease: a double‐blind, placebo controlled multicentre study Human Psychopharmacology-clinical and Experimental. ,vol. 11, pp. 53- 65 ,(1996) , 10.1002/(SICI)1099-1077(199601)11:1<53::AID-HUP761>3.0.CO;2-G
William J. Burke, William H. Roccaforte, Steven P. Wengel, Barbara L. Bayer, Anthony E. Ranno, Nancy K. Willcockson, L‐Deprenyl in the Treatment of Mild Dementia of the Alzheimer Type: Results of a 15–Month Trial Journal of the American Geriatrics Society. ,vol. 41, pp. 1219- 1225 ,(1993) , 10.1111/J.1532-5415.1993.TB07306.X
William J. Burke, Anthony E. Ranno, William H. Roccaforte, Steven P. Wengel, Barbara L. Bayer, Nancy K. Willcockson, L-Deprenyl in the Treatment of Mild Dementia of the Alzheimer Type: Preliminary Results Journal of the American Geriatrics Society. ,vol. 41, pp. 367- 370 ,(1993) , 10.1111/J.1532-5415.1993.TB06942.X
E. Martignoni, G. Bono, F. Blandini, E. Sinforiani, P. Merlo, G. Nappi, Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl Journal of Neural Transmission - Parkinson's Disease and Dementia Section. ,vol. 3, pp. 15- 25 ,(1991) , 10.1007/BF02251133